Posted inInteresting Papers
Anti-VEGF vs. Laser Photocoagulation for ROP: Neurodevelopmental Safety & Clinical Evidence
Target Audience: Retina Specialists & Pediatric Ophthalmologists Source:American Academy of Ophthalmology (AAO) Ophthalmic Technology Assessment-2026 Executive Summary While intravitreal anti-VEGF agents (bevacizumab, ranibizumab, aflibercept) are highly effective for primary treatment…


















